Utah Med (UTMD) - Long-Term Liabilities to Capital

The Utah Medical Products (UTMD) price chart illustrates the efficiency of plastic molding and packaging automation that eliminates manual labor. The current metric stands at 0.00, confirming financial stability characterized by a total absence of debt and strict FDA oversight. The business relies on the demand for neonatology and gynecology instruments; consequently, profits do not correlate with GDP but instead depend on market expansion.

Steady demand for specialized neonatology and gynecology products allows Utah Medical Products to optimize its development financing structure. The long-term debt-to-equity ratio measures the business's reliance on borrowed funds with maturities exceeding one year, which is reflected in the long-term debt-to-equity level as an indicator of financial stability and the cost of servicing resources.